ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for alerts 실시간 알림, 사용자 정의 포트폴리오 및 시장 동향을 받으려면 등록하세요.

LYRA Lyra Therapeutics Inc

5.16
0.00 (0.00%)
시간외 단일가
최종 업데이트: 18:54:40
15분 지연
기업명 주식 심볼 시장 주식 타입
Lyra Therapeutics Inc LYRA 나스닥 보통주
  가격 변동 가격 변동 % 주식 가격 최근 거래 시간
0.00 0.00% 5.16 18:54:40
개장가 저가 고가 종가 전일 종가
5.16
시세 정보 더보기 »

최근 뉴스

일자 시간 출처 제목
01/05/202405:04GLOBELyra Therapeutics Reports First Quarter 2024 Financial..
27/04/202405:51GLOBELyra Therapeutics Announces Inducement Grants Under Nasdaq..
22/03/202405:01GLOBELyra Therapeutics Reports Fourth Quarter and Full Year 2023..
02/03/202406:01GLOBELyra Therapeutics Announces Inducement Grant Under Nasdaq..
15/02/202423:18EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
15/02/202410:35EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
15/02/202408:18EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
15/02/202406:51EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
15/02/202406:18EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
14/02/202406:34EDGAR2Form SC 13G - Statement of acquisition of beneficial..
02/02/202406:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
02/02/202406:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/01/202420:13EDGAR2Form 8-K - Current report
28/12/202320:40EDGAR2Form 8-K - Current report
19/12/202306:16EDGAR2Form 8-K - Current report
17/11/202307:00EDGAR2Form SC 13G - Statement of acquisition of beneficial..
14/11/202307:29EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/11/202306:23EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
08/11/202306:09EDGAR2Form 8-K - Current report
08/11/202306:01GLOBELyra Therapeutics Reports Third Quarter 2023 Financial..
07/11/202321:00GLOBELyra Therapeutics to Participate in Upcoming Investor..
16/10/202320:00GLOBELyra Therapeutics Announces Appointment of Ronan O’Brien as..
13/09/202305:01EDGAR2Form 8-K - Current report
12/09/202320:00GLOBELyra Therapeutics Announces Positive Topline Results from..
06/09/202321:00GLOBELyra Therapeutics to Participate in Upcoming Investor..
02/09/202305:03EDGAR2Form 8-K - Current report
02/09/202305:01EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
29/08/202320:00GLOBELyra Therapeutics Fully Enrolls Pivotal Phase 3 ENLIGHTEN I..
26/08/202305:15EDGAR2Form SC 13G - Statement of acquisition of beneficial..
09/08/202305:15EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
09/08/202305:03EDGAR2Form 8-K - Current report
09/08/202305:01GLOBELyra Therapeutics Reports Second Quarter 2023 Financial..
15/07/202305:06EDGAR2Form 8-K - Current report
13/07/202320:30GLOBELyra Therapeutics to Present at William Blair Virtual..
13/07/202307:36EDGAR2Form 4/A - Statement of changes in beneficial ownership of..
08/07/202305:44EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
06/07/202310:50EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/07/202310:49EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/07/202310:46EDGAR2Form 4 - Statement of changes in beneficial ownership of..
29/06/202305:06EDGAR2Form S-3 - Registration statement under Securities Act of..
03/06/202305:01GLOBELyra Therapeutics Announces Inducement Grant Under Nasdaq..
02/06/202320:30GLOBELyra Therapeutics to Present at Jefferies Healthcare..
01/06/202320:29GLOBELyra Therapeutics Announces Closing of $50.0 Million Private..
26/05/202320:57GLOBELyra Therapeutics Announces $50.0 Million Private Placement
12/05/202320:00GLOBELyra Therapeutics Reports First Quarter 2023 Financial..
10/05/202305:01GLOBELyra Therapeutics to Present at Bank of America Securities..

최근 히스토리

Delayed Upgrade Clock